Adolescents and adults at clinical high-risk for psychosis: Age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms

Psychological Medicine

Volumn 46, Issue 5, 2016, Pages 1069-1078

  Gerstenberg, M ^a,b   Theodoridou, A ^a   Traber Walker, N ^b   Franscini, M ^b   Wotruba, D ^a,c,d   Metzler, S ^a   Muller M ^a   Dvorsky, D ^a   Correll, C U ^e,f,g,h   Walitza, S ^b   Rossler W ^a,d,i   Heekeren, K ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY ZURICH   (Switzerland)

^b University Clinics for Child and Adolescent Psychiatry   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^g FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescents; at risk for psychosis; attenuated positive symptoms; basic symptoms; cognitive disturbances; psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE; CLASSIFICATION; FEMALE; HUMAN; MALE; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUICIDE; SWITZERLAND; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUICIDE; SWITZERLAND; YOUNG ADULT;

EID: 84949811539     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715002627     Document Type: Article

References (41)

1. Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R (2007). North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin 33, 665-672.
2. Addington J, Heinssen R (2012). Prediction and prevention of psychosis in youth at clinical high risk. Annual Review of Clinical Psychology 8, 269-289.
3. APA (2013). Diagnostic and Statistical Manual ofMental Disorders, 5th edn. American Psychiatric Association: Arlington, VA.
4. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J (2005). The HCL-32: towards a self-Assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders 88, 217-233.
5. Arango C (2011). Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. European Child & Adolescent Psychiatry 20, 67-70.
6. Beck AT, Epstein N, Brown G, Steer RA (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 56, 893-897.
7. Corcoran C, First M, Cornblatt B (2010). The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk-benefit analysis. Schizophrenia Research 120, 16-22.
8. Correll CU, Hauser M, Auther AM, Cornblatt BA (2010). Research in people with psychosis risk syndrome: A review of the current evidence and future directions. Journal of Child Psychology and Psychiatry, and Allied Disciplines 51, 390-431.
9. Dunn LM, Dunn LM, Bulheller S, Häcker H (1965). Peabody Picture Vocabulary Test. American Guidance Service: Circle Pines, MN.
10. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, KemptonMJ, Valmaggia L, Barale F, Caverzasi E, Mcguire P (2012). Predicting psychosis. Archives of General Psychiatry 69, 220-229.
11. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A (2013). The psychosis high-risk state: A comprehensive state-of-The-Art review. JAMA Psychiatry 70, 107-120.
12. Gaudiano BA, Zimmerman M (2013). Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic. Journal of Clinical Psychiatry 74, 149-155.
13. Gerstenberg M, Hauser M, Al-Jadiri A, Sheridan EM, Kishimoto T, Borenstein Y, Vernal DL, David L, Saito E, Landers SE, Carella M, Singh S, Carbon M, Jiménez-Fernández S, Birnbaum ML, Auther A, Carrión RE, Cornblatt BA, Kane JM, Walitza S, Correll CU (2015). Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with non-psychotic psychiatric disorders. Journal of Clinical Psychiatry 76, e1449-e1458.
14. Guy W (1976). Clinical Global Impression Scale. The ECDEU Assessment Manual for Psychopharmacology-Revised. US Department of Heath, Education, andWelfare Public Health Service Alcohol, Drug Abuse, and Mental Health Admini stration, DHEW Publication: Rockville, MD, pp. 218-222.
15. Hall RC (1995). Global assessment of functioning. A modified scale. Psychosomatics 36, 267-275.
16. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-63.
17. Kay S, Fiszbein A, Opler L (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
18. Kelleher I, Corcoran P, Keeley H, Wigman JTW, Devlin N, Ramsay H, Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, Cannon M (2013). Psychotic symptoms and population risk for suicide attempt: A prospective cohort study. JAMA Psychiatry 140, 1-9.
19. Kelleher I, Murtagh A, Molloy C, Roddy S, Clarke MC, Harley M, Cannon M (2012). Identification and characterization of prodromal risk syndromes in young adolescents in the community: A population-based clinical interview study. Schizophrenia Bulletin 38, 239-246.
20. Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Linszen D, Birchwood M, Juckel G, Morrison A, Vázquèz-Barquero JL, Hambrecht M, VON Reventlow H (2005). The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 4, 161-167.
21. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, Janavs J, Dunbar G (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 12, 224-231.
22. Lehrl S, Triebig G and Fischer B (1995). Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurologica Scandinavica 91, 335-345.
23. Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, Huttunen M, Cannon TD, Suvisaari J, Therman S (2014). Predicting psychosis in a general adolescent psychiatric sample. Schizophrenia Research 158, 1-6.
24. McGlashan T, Walsh B, Woods S (2010). The Psychosis-Risk Syndrome. Handbook for Diagnosis and Follow-Up. Oxford University Press: New York, NY.
25. Metzler S, Dvorsky D, Wyss C, Müller M, Traber-Walker N, Walitza S, Theodoridou A, Rössler W, Heekeren K (2014). Neurocognitive profiles in help-seeking individuals: comparison of risk for psychosis and bipolar disorder criteria. Psychological Medicine 44, 3543-3555.
26. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, von Reventlow HG, Klosterkötter J, Article O (2010). Prediction of psychosis in adolescents and young adults at high risk. Archives of General Psychiatry 67, 241-251.
27. Schimmelmann B, Walger P, Schultze-Lutter F (2013). The significance of at-risk symptoms for psychosis in children and adolescents. Canadian Journal of Psychiatry 58, 32-40.
28. Schimmelmann BG, Schultze-Lutter F (2012). Early detection and intervention of psychosis in children and adolescents: urgent need for studies. European Child & Adolescent Psychiatry 21, 239-241.
29. Schultze-Lutter F (2007). Predicting first-episode psychosis by basic symptom criteria. Clinical Neuropsychiatry 4, 11-22.
30. Schultze-Lutter F, Klosterkötter J, Ruhrmann S (2014). Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophrenia Research 154, 100-106.
31. Schultze-Lutter F, Koch E (2010). Schizophrenia Proneness Instrument, Child & Youth Version (SPI-CY). Giovanni Fioriti Editore s. r. l. : Roma.
32. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG (2013). Prevalence and clinical significance of DSM-5-Attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) Study. Schizophrenia Bulletin 40, 1499-1508.
33. Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Ruhrmann S, Klosterkötter J (2015). EPA guidance on the early detection of clinical high risk states of psychoses. European Psychiatry 30, 405-416.
34. Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, Milo KM, Stock SL, Wilkinson B (2010). Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). Journal of Clinical Psychiatry 71, 313-326.
35. Theodoridou A, Heekeren K, Dvorsky D, Metzler S, Franscini M, Haker H, Kawohl W, Rüsch N, Walitza S, Rössler W (2014). Early recognition of high risk of bipolar disorder and psychosis: An overview of the ZInEP 'Early Recognition' Study. Frontiers in Public Health 2, 166.
36. Welsh P, Tiffin PA(2012). Experience of child and adolescent mental health clinicians working within an at-risk mental state for psychosis service: A qualitative study. Early Intervention in Psychiatry 6, 207-211.
37. Welsh P, Tiffin PA (2014). The 'At-Risk Mental State' for psychosis in adolescents: clinical presentation, transition and remission. Child Psychiatry and Human Development 45, 90-98.
38. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH (2013). Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophrenia Research 148, 99-104.
39. Yang LH, Wonpat-Borja AJ, Opler MG, Corcoran CM (2010). Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question. Schizophrenia Research 120, 42-48.
40. Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, Klosterkötter J, Kwon JS, McGorry PD, McGuire P, Mizuno M, Morrison AP, Riecher-Rössler A, Salokangas RKR, Seidman LJ, Suzuki M, Valmaggia L, van der Gaag M, Wood SJ, McGlashan TH (2012). Whither the attenuated psychosis syndrome? Schizophrenia Bulletin 38, 1130-1134.
41. Ziermans TB, Schothorst PF, Sprong M, van Engeland H (2011). Transition and remission in adolescents at ultra-high risk for psychosis. Schizophrenia Research 126, 58-64.